Family Health Insurance Is No Longer Affordable Through Small Employers November 28, 2023 Perspective In his Beyond the Data column, KFF President and CEO Drew Altman discusses how how family health coverage is no longer affordable for workers at small employers, contributing to the health cost crisis affecting the American people.
Complexity in Our Health Care System is the Enemy of Access and Affordability October 26, 2023 Perspective In this JAMA Health Forum column, KFF’s Drew Altman and Larry Levitt examine how the complexity of the health care system – with all of its red tape – can be as big a problem for patients as the traditional big three problems of costs, quality and access.
The 4 Arguments You Will Hear Against Drug Price Negotiation September 6, 2023 Perspective As the Biden administration begins the process of negotiation drug prices for Medicare as authorized in the Inflation Reduction Act, KFF’s Larry Levitt probes some of the arguments against it and the policy and political implications of the debate in this New York Times op-ed column.
Health Care Issues in the Early Stages of the 2024 Election July 20, 2023 Perspective In this JAMA Health Forum column, Larry Levitt examines differences in the Republican presidential candidates’ records and positions on health issues, including Medicaid and abortion, that could play a role in the primaries and would set up a sharp contrast in the general election against President Biden.
A Focus on Contraception in the Wake of Dobbs June 13, 2023 Perspective In this commentary for Women’s Health Issues, a publication of the Jacobs Institute of Women’s Health, KFF experts discuss contraceptive coverage and financing policies, access points within the delivery system, and the role of mis- and disinformation.
PEPFAR Reauthorization on the Horizon April 14, 2023 Perspective In this Think Global opinion piece, Jennifer Kates and Kellie Moss discuss what could happen if the United States’ signature initiative on global health is not reauthorized.
Increasingly Privatized Public Health Insurance Programs in the US March 30, 2023 Perspective In this JAMA Forum column, KFF’s Larry Levitt examines the growing role of private insurance companies in public programs, including Medicare Advantage and Medicaid managed care, and the tradeoffs that result.
The Commercialization of Covid Vaccines Is Coming. Here’s What It Means. February 18, 2023 Perspective In this commentary for Barron’s, KFF’s Cynthia Cox and Jennifer Kates explore what will happen with costs to COVID-19 vaccines for people with and without insurance once the relevant public health emergency ends on May 11.
Medicaid as a Potential New Third Rail of US Politics December 22, 2022 Perspective In this JAMA Forum column, KFF’s Larry Levitt examines Medicaid’s growing political importance and the potential double whammy that could hit state Medicaid programs next year with the end of the COVID-19 public health emergency and a possible simultaneous recession.
The Inflation Reduction Act is a Foot in the Door for Containing Health Care Costs August 25, 2022 Perspective In this column for the JAMA Forum, KFF’s Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.